Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    17156920 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain
Conditions: Cancer;   Pain
Interventions: Drug: oxycodone;   Drug: pregabalin
2 Enrolling by invitation Patient Controlled Analgesia Pharmacogenetic Study
Condition: Pain
Intervention:
3 Enrolling by invitation Multicenter Perioperative Opioid Pharmacogenetic Study
Condition: Pain
Intervention:
4 Enrolling by invitation Pharmacogenetic Morphine Spine Study
Condition: Pain
Intervention:

Indicates status has not been verified in more than two years